Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/B ratio high or low?
The P/B ratio of 0.88 is 23% below its estimated 1-year average of 1.14, near the low end of its estimated 1-year range (0.85–1.46).
As of 2026-10-06T14:16:31.927Z.
Calculation as of: 2026-10-06T14:16:31.927Z.
Quote observation: 2026-10-06T14:15:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b2d28e84da0c930e75004ae600b803967d1975629f72cad3bf33ad83c9831f21
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
0.88
PB RATIO AVG TTM
N/A
PB RATIO AVG 3Y
N/A
PB RATIO AVG 5Y
N/A
PB RATIO AVG 10Y
N/A
PB RATIO AVG 15Y
N/A
PB RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.44
median of 505 covered companies
CURRENT VS SECTOR MEDIAN
-63.93%
vs the sector median at left
Eikon Therapeutics, Inc. Common Stock
Market Cap
$411.75M
PB Ratio
0.88
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$377.74M
PB Ratio
2.20
TTM Avg
1.24
3Y Avg
1.89
5Y Avg
2.28
Market Cap
$433.92M
PB Ratio
1.76
TTM Avg
6.76
3Y Avg
9.79
5Y Avg
10.19
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. Common Stock (EIKN) | $411.75M | 0.88 | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $410.49M | 4.87 | 2.97 | 2.97 | 2.97 |
| Shoulder Innovations, Inc. (SI)vs › | $408.44M | 3.29 | 2.49 | 2.49 | 2.49 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $404.94M | 1.98 | 1.37 | 0.85 | 0.86 |
| Myriad Genetics, Inc. (MYGN)vs › | $416.52M | 1.37 | 1.38 | 1.80 | 1.87 |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $377.74M | 2.20 | 1.24 | 1.89 | 2.28 |
| Editas Medicine, Inc. (EDIT)vs › | $429.68M | 4.08 | 24.41 | 9.76 | 6.69 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $433.92M | 1.76 | 6.76 | 9.79 | 10.19 |
| Assembly Biosciences, Inc. (ASMB)vs › | $434.00M | 1.42 | 2.81 | 3.05 | 2.11 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $380.98M | 1.09 | 2.57 | 2.57 | 2.57 |
At 0.88, P/B is below its estimated 1-year median — higher than 8% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
0.85
median
1.16
estimated 1-year high
1.46
P/B Ratio
0.88
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PB RATIO |
|---|---|
| 2026-10-05 | 0.88 |
| 2026-10-02 | 0.85 |
| 2026-10-01 | 0.86 |
| 2026-09-30 | 0.93 |
| 2026-09-29 | 0.92 |
| 2026-09-28 | 0.92 |
| 2026-09-25 | 0.92 |
| 2026-09-24 | 0.96 |
| 2026-09-23 | 0.94 |
| 2026-09-22 | 1.04 |
| 2026-09-21 | 1.02 |
| 2026-09-18 | 1.04 |
| 2026-09-17 | 1.00 |
| 2026-09-16 | 0.99 |
| 2026-09-15 | 1.10 |
| 2026-09-14 | 1.09 |
| 2026-09-11 | 1.04 |
| 2026-09-10 | 1.07 |
| 2026-09-09 | 1.25 |
| 2026-09-08 | 1.24 |
| 2026-09-04 | 1.26 |
| 2026-09-03 | 1.27 |
| 2026-09-02 | 1.32 |
| 2026-09-01 | 1.26 |
| 2026-08-31 | 1.21 |
| 2026-08-28 | 1.27 |
| 2026-08-27 | 1.34 |
| 2026-08-26 | 1.39 |
| 2026-08-25 | 1.46 |
| 2026-08-24 | 1.30 |
| 2026-08-21 | 1.32 |
| 2026-08-20 | 1.25 |
| 2026-08-19 | 1.39 |
| 2026-08-18 | 1.35 |
| 2026-08-17 | 1.22 |
| 2026-08-14 | 1.28 |